Search results
Feb 4, 2010 · W. Ian Lipkin, MD, the John Snow Professor of Epidemiology at Columbia University’s Mailman School of Public Health, professor of neurology and pathology at Columbia University Medical Center, and director of the Mailman School’s Center for Infection and Immunity (CII), has been named to the board of Editors of the American Society for Microbiology’s (ASM) journal, mBio. An expert in ...
W. Ian Lipkin, MD, is the John Snow Professor of Epidemiology and Director of the Center for Infection and Immunity at the Mailman School of Public Health at Columbia University, and Director of the Global Alliance for Preventing Pandemics.
Dec 1, 2012 · We discuss challenges to their control and new efforts to predict pandemics, target surveillance to the most crucial interfaces, and identify prevention strategies. New mathematical modelling, diagnostic, communications, and informatics technologies can identify and report hitherto unknown microbes in other species, and thus new risk assessment ...
Jun 7, 2021 · Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) an illness that can occur in sporadic or epidemic form; is often preceded by an infectious-like illness; and includes fatigue, cognitive problems, a flare of symptoms following physical, cognitive, or emotional stressors (postexertional malaise), disrupted sleep, and orthostatic ...
Biography. "W. Ian Lipkin, MD, is internationally recognized as an authority on the use of molecular methods for pathogen discovery and the role of infection in neurologic and neuropsychiatric diseases. Dr. Lipkin has over 30 years of experience in diagnostics, microbial discovery and outbreak response. He has mentored and trained over 30 ...
Feb 24, 2022 · W. Ian Lipkin is the Director of the Global Alliance for Preventing Pandemics, a program dedicated to enhancing global surveillance through capacity building and data sharing. References 1.
W. Ian Lipkin is the John Snow Professor of Epidemiology, Professor of Neurology & Pathology, and Director of the Center for Infection and Immunity (CII) at Columbia University and the NIH Center for Diagnostics and Discovery. His contributions include the first use of subtractive cloning and deep sequencing in pathogen discovery.
